Select Publications
Book Chapters
2012, 'Introduction', in Ramraj V; Hor M; Roach K (ed.), Global Anti-Terrorism Law and Policy, Cambridge University Press, UK, pp. 1 - 17
,Journal articles
2024, 'Patterns of medicine use in the year prior to death by suicide: an Australian population-based case series study', eClinicalMedicine, 77, http://dx.doi.org/10.1016/j.eclinm.2024.102858
,2024, 'Post-discharge pharmacotherapy in people with atrial fibrillation hospitalised for acute myocardial infarction: an Australian cohort study 2018-2022.', Eur Heart J Qual Care Clin Outcomes, http://dx.doi.org/10.1093/ehjqcco/qcae068
,2024, 'The Medicines Intelligence Data Platform: A Population-Based Data Resource From New South Wales, Australia', Pharmacoepidemiology and Drug Safety, 33, http://dx.doi.org/10.1002/pds.5887
,2024, 'Changes in sick notes associated with COVID-19 from 2020 to 2022: A cohort study in 24 million primary care patients in OpenSAFELY-TPP', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-080600
,2024, 'Changes in opioid prescribing during the COVID-19 pandemic in England: an interrupted time-series analysis in the OpenSAFELY-TTP cohort', The Lancet Public Health, 9, pp. e432 - e442, http://dx.doi.org/10.1016/S2468-2667(24)00100-2
,2024, 'Impact of coordinated care on adherence to antihypertensive medicines among adults experiencing polypharmacy in Australia', Journal of Hypertension, 42, pp. 1248 - 1255, http://dx.doi.org/10.1097/HJH.0000000000003721
,2024, 'The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records', British Journal of Clinical Pharmacology, 90, pp. 1600 - 1614, http://dx.doi.org/10.1111/bcp.16030
,2024, 'Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults: an OpenSAFELY analysis', eClinicalMedicine, 72, http://dx.doi.org/10.1016/j.eclinm.2024.102638
,2024, 'OpenSAFELY: A platform for analysing electronic health records designed for reproducible research', Pharmacoepidemiology and Drug Safety, 33, http://dx.doi.org/10.1002/pds.5815
,2024, 'Quality use of publicly subsidised tapentadol in Australia: a population-based analysis', Internal Medicine Journal, 54, pp. 941 - 950, http://dx.doi.org/10.1111/imj.16335
,2024, 'Trends in weight gain recorded in English primary care before and during the Coronavirus-19 pandemic: An observational cohort study using the OpenSAFELY platform', PLoS Medicine, 21, http://dx.doi.org/10.1371/journal.pmed.1004398
,2024, 'Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)', The Lancet Regional Health - Europe, 40, http://dx.doi.org/10.1016/j.lanepe.2024.100908
,2024, 'Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy', Neurology, 102, http://dx.doi.org/10.1212/WNL.0000000000207996
,2024, 'OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate', British Journal of Clinical Pharmacology, http://dx.doi.org/10.1111/bcp.16062
,2023, 'Clinical and health inequality risk factors for non-COVID-related sepsis during the global COVID-19 pandemic: a national case-control and cohort study', eClinicalMedicine, 66, http://dx.doi.org/10.1016/j.eclinm.2023.102321
,2023, 'Implementing Germ Defence digital behaviour change intervention via all primary care practices in England to reduce respiratory infections during the COVID-19 pandemic: an efficient cluster randomised controlled trial using the OpenSAFELY platform', Implementation Science, 18, http://dx.doi.org/10.1186/s13012-023-01321-z
,2023, 'Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform', The Lancet Regional Health - Europe, 34, http://dx.doi.org/10.1016/j.lanepe.2023.100741
,2023, 'Substances Detected during Coroner Postmortem Toxicology Analyses in Poisoning- and Nonpoisoning-Related Suicides', JAMA Psychiatry, 80, pp. 1121 - 1130, http://dx.doi.org/10.1001/jamapsychiatry.2023.2289
,2023, 'Five healthcare trajectories in the year before suicide and what they tell us about opportunities for prevention: a population-level case series study', eClinicalMedicine, 63, http://dx.doi.org/10.1016/j.eclinm.2023.102165
,2023, 'Opioid prescribing patterns among medical practitioners in New South Wales, Australia', Drug and Alcohol Review, 42, pp. 1472 - 1481, http://dx.doi.org/10.1111/dar.13675
,2023, 'Five-Year Trajectories of Prescription Opioid Use', JAMA Network Open, 6, pp. E2328159, http://dx.doi.org/10.1001/jamanetworkopen.2023.28159
,2023, 'Psychotropic and other medicine use at time of death by suicide: a population-level analysis of linked dispensing and forensic toxicology data', Medical Journal of Australia, 219, pp. 63 - 69, http://dx.doi.org/10.5694/mja2.51985
,2023, 'Persistence and Adherence to Cardiovascular Medicines in Australia', Journal of the American Heart Association, 12, pp. e030264, http://dx.doi.org/10.1161/JAHA.122.030264
,2023, 'Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform', eClinicalMedicine, 61, http://dx.doi.org/10.1016/j.eclinm.2023.102077
,2023, 'Blood, dose recommendation reports and phone calls: Experiences of a therapeutic drug monitoring advisory service for vancomycin', British Journal of Clinical Pharmacology, 89, pp. 1896 - 1902, http://dx.doi.org/10.1111/bcp.15668
,2023, 'Potential drug–drug interactions due to concomitant medicine use among people living with HIV on antiretroviral therapy in Australia', British Journal of Clinical Pharmacology, 89, pp. 1541 - 1553, http://dx.doi.org/10.1111/bcp.15614
,2023, 'The effects of the 4/20 cannabis holiday and adult-use cannabis legalization on medical cannabis sales and medical cannabis patient registration in Arizona', International Journal of Drug Policy, 114, http://dx.doi.org/10.1016/j.drugpo.2023.103974
,2022, 'The association between psychostimulant use in pregnancy and adverse maternal and neonatal outcomes: results from a distributed analysis in two similar jurisdictions.', International Journal of Epidemiology, 52, pp. 190 - 202, http://dx.doi.org/10.1093/ije/dyac180
,2022, 'Prescribed medicine use and extent of off-label use according to age in a nationwide sample of Australian children', Paediatric and Perinatal Epidemiology, 36, pp. 726 - 737, http://dx.doi.org/10.1111/ppe.12870
,2022, 'Trends in dispensing and utilisation of sustained-release tapentadol in Australia.', International Journal of Population Data Science, 7, http://dx.doi.org/10.23889/ijpds.v7i3.1978
,2022, 'Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID- 19 pandemic in Australia', PLoS ONE, 17, pp. e0269482, http://dx.doi.org/10.1371/journal.pone.0269482
,2022, 'Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancer', Lung Cancer, 166, pp. 40 - 48, http://dx.doi.org/10.1016/j.lungcan.2022.01.024
,2022, 'Assessing the impact of implementing multiple adherence measures to antiretroviral therapy from dispensing data: a short report', AIDS Care: psychological and socio-medical aspects of AIDS-HIV, 35, pp. 970 - 975, http://dx.doi.org/10.1080/09540121.2022.2050179
,2022, 'Changes in antibiotic prescribing following COVID-19 restrictions: Lessons for post-pandemic antibiotic stewardship', British Journal of Clinical Pharmacology, 88, pp. 1143 - 1151, http://dx.doi.org/10.1111/bcp.15000
,2022, 'The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis', Pharmacoepidemiology and Drug Safety, 31, pp. 370 - 378, http://dx.doi.org/10.1002/pds.5395
,2022, 'Evidence-practice gaps in P2Y
2022, 'Changes in antidepressant use in Australia: A nationwide analysis (2015–2021)', Australian and New Zealand Journal of Psychiatry, 57, http://dx.doi.org/10.1177/00048674221079740
,2022, 'Gabapentinoids: repeating mistakes of the past?', Addiction, 117, pp. 2969 - 2971, http://dx.doi.org/10.1111/add.15970
,2022, 'A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia', Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 42, pp. 828 - 836, http://dx.doi.org/10.1002/phar.2735
,2021, 'Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions', BMC Medical Research Methodology, 21, pp. 58, http://dx.doi.org/10.1186/s12874-021-01235-8
,2021, 'Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study', The Lancet Regional Health - Western Pacific, 14, pp. 100226, http://dx.doi.org/10.1016/j.lanwpc.2021.100226
,2021, 'Psychotropic medicine prescribing and polypharmacy for people with dementia entering residential aged care: the influence of changing general practitioners', Medical Journal of Australia, 215, pp. 130 - 136, http://dx.doi.org/10.5694/mja2.51153
,2021, 'Real-world data to advance HER2-targeted cancer medicines research: Playing to the strengths of clinical registry and administrative data', Asia-Pacific Journal of Clinical Oncology, 17, pp. 414 - 415, http://dx.doi.org/10.1111/ajco.13554
,2021, 'Are clinical trial eligibility criteria representative of older patients with lung cancer? A population-based data linkage study', Journal of Geriatric Oncology, 12, pp. 930 - 936, http://dx.doi.org/10.1016/j.jgo.2021.02.003
,2021, 'Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based study', Breast Cancer Research and Treatment, 187, pp. 893 - 902, http://dx.doi.org/10.1007/s10549-021-06135-5
,2021, 'The changing face of Australian data reforms: Impact on pharmacoepidemiology research', International Journal of Population Data Science, 6, pp. 1418, http://dx.doi.org/10.23889/ijpds.v6i1.1418
,2021, 'Patterns of opioid use in older people diagnosed with cancer in New South Wales, Australia', Pharmacoepidemiology and Drug Safety, 30, pp. 360 - 370, http://dx.doi.org/10.1002/pds.5081
,2021, 'Coming to grips with seemingly conflicting results in programme evaluation: The devil's in the detail', BMJ Quality and Safety, 30, pp. 70 - 71, http://dx.doi.org/10.1136/bmjqs-2020-012118
,2021, 'Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis', Clinical Pharmacology and Therapeutics, 109, pp. 212 - 221, http://dx.doi.org/10.1002/cpt.2113
,